While we are cross referencing, here is a link to the thread I posted in the Meeting Highlights, containing information about the deleterious effects of chemotherapy on insulin resistance:
http://her2support.org/vbulletin/sho...eferrerid=1173
Clearly, BC treatment (and the premeds for the treatment) are contributing to on-going weight issues for patients, which in turn contribute to recurrence. Considering how many of these treatments are given to early stagers as risk management against recurrence, it is not clear exactly what risk is being managed.
Hopeful
Hybrid Mode
